- •Uveitis
- •Foreword
- •Preface
- •Dedication
- •Acknowledgments
- •Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis
- •Elements of the immune system
- •Macrophages/monocytes
- •Dendritic cells
- •T cells
- •Major subsets of T cells
- •Cytokines
- •T-cell subsets
- •T-regulatory cells
- •T-cell receptor
- •Chemokines
- •Thymic expression and central immune tolerance
- •B cells
- •Classes of Immunoglobulin
- •Other cells
- •Mast Cells
- •Eosinophils
- •Neutrophils
- •Resident Ocular Cells
- •Complement system
- •Cellular interactions: hypersensitivity reactions
- •Classic immune hypersensitivity reactions
- •Type I
- •Type II
- •Type III
- •Type IV
- •Type V
- •Concepts of disease pathogenesis
- •Immune characteristics of the eye
- •Absence of lymphatic drainage
- •Intraocular microenvironment
- •Anterior Chamber-Associated Immune Deviation (ACAID)
- •Fas-Fas Ligand Interactions and Programmed Cell Death (Apoptosis)
- •Resident Ocular Cells and Immune System
- •Cytokines and Chemokines and the Eye
- •Oral Tolerance
- •Choroidal circulation and anatomy
- •Retina
- •Immunogenetics
- •Class I antigens
- •Class II and class III antigens
- •Histocompatibility lymphocyte antigens
- •Single-nucleotide polymorphisms (SNPs)
- •Epigenetics
- •Immune complex-mediated disease
- •Gene expression profiling
- •Tissue damage in the eye
- •T-cell responses and autoimmunity
- •T-cell receptor and the expression of disease
- •Ocular autoimmunity
- •Uveitogenic antigens
- •Retinal S-Antigen (Arrestin)
- •Interphotoreceptor Retinoid-Binding Protein
- •Recoverin
- •Bovine Melanin Protein
- •Rhodopsin
- •Phosducin
- •Tyrosinase
- •Other Antigens
- •Endotoxin and Other Bacterial Antigens
- •Importance of Antigen Studies
- •Cell adhesion molecules and their role in lymphocyte homing and in disease
- •Immune responses to invading viruses and parasites
- •Suggested Readings
- •References
- •Medical History in the Patient with Uveitis
- •References
- •Sample Uveitis Questionnaire
- •FAMILY HISTORY
- •SOCIAL HISTORY
- •PERSONAL MEDICAL HISTORY
- •MEDICAL HISTORY
- •Examination of the Patient with Uveitis
- •Visual acuity
- •External examination
- •Pupils and extraocular muscles
- •Intraocular pressure measurement
- •Slit-lamp biomicroscopy
- •Conjunctiva
- •Cornea
- •Keratic Precipitates
- •Other Corneal Findings
- •Anterior chamber
- •Iris
- •Anterior chamber angle
- •Lens
- •Vitreous
- •Retina and choroid
- •Optic nerve
- •References
- •Development of a Differential Diagnosis
- •Forming a differential diagnosis
- •Classifying uveitis
- •Is the disease acute or chronic?
- •Is the inflammation granulomatous or nongranulomatous?
- •Is the disease unilateral or bilateral?
- •Where is the inflammation located in the eye?
- •What are the demographics of the patient?
- •What associated symptoms does the patient have?
- •What associated signs are present on physical examination?
- •What is the time course of the disease and response to previous therapy?
- •Case 4-1
- •Case 4-2
- •References
- •Diagnostic Testing
- •Pretest likelihood of disease
- •Receiver operating characteristic (ROC) curve
- •Diagnostic tests for uveitis
- •Laboratory tests
- •Image analysis
- •Skin testing
- •Tissue samples
- •Ancillary ophthalmic tests
- •Electrophysiology
- •Laser interferometry
- •Fluorescein angiography
- •Indocyanine green
- •Laser flare photometry
- •Optical coherence tomography
- •High-frequency ultrasound biomicroscopy and multifrequency ultrasound
- •Fundus autofluorescence
- •Other diagnostic tests
- •Polymerase chain reaction (PCR)
- •Rapid tests for herpes simplex and herpes zoster
- •Bone mineral density studies
- •Genetic testing for steroid-induced glaucoma
- •Neurologic tests
- •References
- •Evidence-Based Medicine in Uveitis
- •Study design
- •Clinical trials in uveitis
- •References
- •Philosophy, Goals, and Approaches to Medical Therapy
- •Goals and philosophy
- •Pain, photophobia, and discomfort
- •Degree and location of inflammatory disease
- •Evaluation of visual acuity and prospect of reversibility
- •Follow-up procedures and standardization of observations
- •General health and age of patient
- •Patient reliability, preferences, and understanding
- •Nonsurgical therapeutic options
- •Corticosteroids
- •Mode of Action
- •Preparations, Dosage Schedules, and Complications
- •Ozurdex.
- •Secondary Effects
- •Cytotoxic agents
- •Alkylating agents
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Antimetabolites
- •Azathioprine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mycophenolate mofetil
- •Methotrexate
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Ciclosporin
- •Mode of Action
- •Dosages and Indications
- •Secondary Effects
- •Tacrolimus
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Lx 211 (Voclosporin)
- •Rapamycin
- •Mode of Action
- •Indications and Dosages
- •Toxicity
- •Antibodies and monoclonal antibodies
- •Daclizumab
- •Etanercept
- •Infliximab (Remicade)
- •Adalimumab (Humira)
- •Efalizumab (Raptiva)
- •Rituximab (Rituxan)
- •Anakinra (Kineret)
- •Alemtuzumab (Campath-1H)
- •Abatacept (Orencia)
- •Intravenous immunoglobulin therapy
- •Oral tolerance
- •Interferon-α
- •Antiviral therapy
- •Aciclovir
- •Ganciclovir
- •Valaciclovir
- •Famciclovir
- •Foscarnet
- •Combined ganciclovir and foscarnet
- •Cidofovir
- •Fomivirsen
- •Colchicine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mydriatic and cycloplegic agents
- •Antitoxoplasmosis therapy
- •Other therapeutic approaches
- •Immunostimulators
- •Plasmapheresis
- •Nonsteroidal antiinflammatory agents
- •References
- •Role of Surgery in the Patient with Uveitis
- •Considerations
- •Removal of band keratopathy
- •Corneal transplantation
- •Cataract surgery
- •Glaucoma surgery
- •Treatment of vitreoretinal disease
- •Laser treatment
- •Photodynamic therapy
- •Diagnostic surgery
- •Anterior chamber paracentesis
- •Chorioretinal biopsy
- •Subretinal surgery
- •Case 8-1
- •References
- •Bacterial and Fungal Diseases
- •Introduction
- •Leprosy
- •Clinical findings
- •Immunology and pathology
- •Therapy
- •Tuberculosis
- •Systemic disease
- •Ocular disease
- •Diagnosis
- •Therapy
- •Other bacterial infections
- •Brucellosis
- •Whipple’s disease
- •Treatment and prognosis
- •Chronic granulomatous disease
- •Fungal disease
- •Neuroretinitis
- •References
- •Spirochetal Diseases
- •Spirochetal infections and the eye
- •Spirochetes
- •Definition
- •Venereal treponemal diseases
- •Syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Primary syphilis.
- •Secondary syphilis.
- •Latent syphilis.
- •Tertiary syphilis.
- •Benign tertiary syphilis.
- •Cardiovascular syphilis.
- •Neurosyphilis.
- •Congenital syphilis.
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •General recommendations.
- •Approach to Syphilis in Patients with AIDS
- •Nonvenereal treponematoses
- •Endemic syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Yaws and pinta
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Borrelia infection
- •Lyme disease
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Relapsing fever
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Leptospirosis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Weil’s disease
- •Diagnosis
- •Prognosis
- •Treatment
- •Case 10-1
- •References
- •Acquired Immunodeficiency Syndrome
- •Human immunodeficiency virus
- •Epidemiology
- •Diagnosis
- •HIV disease
- •HIV therapy
- •Ocular manifestations of HIV infection
- •Ocular infection
- •Cytomegalovirus retinitis
- •Progression
- •CMV retinitis in the era of highly active antiretroviral therapy
- •Treatment
- •Intravitreal ganciclovir implant
- •Current therapeutic approach to CMV retinitis in the era of HAART
- •Retinal detachment
- •Prognosis
- •Immune recovery uveitis
- •Herpes zoster
- •Pneumocystis jirovecii choroiditis
- •Mycobacterium avium-intracellulare choroiditis
- •Other diseases
- •Drug-related ocular inflammation
- •Case 11-1
- •Case 11-2
- •References
- •Acute retinal necrosis
- •Epidemiology
- •Clinical features
- •Etiology
- •Differential diagnosis
- •Therapy
- •Progressive outer retinal necrosis
- •Diagnosis
- •Differential diagnosis
- •Etiology
- •Therapy
- •Case 12-1
- •Case 12-2
- •References
- •Other Viral Diseases
- •Herpes simplex virus kerititis and keratouveitis
- •Pathogenesis
- •Diagnosis
- •Treatment
- •Herpes zoster ophthalmicus
- •Treatment
- •West Nile virus
- •Epidemiology
- •Diagnosis
- •Clinical description
- •Ophthalmic manifestations
- •Treatment
- •Prognosis
- •Other viral infections
- •Human T-lymphotropic virus type I
- •Case 13-1
- •References
- •Ocular Toxoplasmosis
- •Organism
- •Clinical manifestations
- •Systemic
- •Ocular
- •Decreased Vision
- •Loss of Vision
- •Effects in immunocompromised host
- •Histopathology and immune factors
- •Immune response
- •Inflammatory response
- •Methods of diagnosis
- •Pregnancy
- •Other methods
- •Congenital versus acquired disease
- •Therapy
- •Additional therapeutic approaches
- •Case 14-1
- •Case 14-2
- •Case 14-3
- •Case 14-4
- •References
- •Ocular Histoplasmosis
- •Systemic findings
- •Ocular appearance
- •‘Histo’ spots
- •Maculopathy
- •Peripapillary pigment changes
- •Clear vitreous
- •Etiology and immunology
- •Nonsurgical therapies
- •Laser therapy
- •Subretinal surgery
- •References
- •Toxocara canis
- •Ocular manifestations
- •Histopathology and immune factors
- •Enzyme-linked immunoabsorbent assay
- •Treatment
- •Case 16-1
- •References
- •Onchocerciasis and Other Parasitic Diseases
- •Onchocerciasis
- •Clinical appearance
- •Immune characteristics
- •Therapy
- •Giardiasis
- •Ophthalmomyiasis
- •Cysticercosis
- •Caterpillar hairs
- •Amebiasis
- •Diffuse unilateral subacute neuroretinitis (DUSN)
- •Malaria
- •Seasonal hyperacute panuveitis (SHAPU)
- •References
- •Postsurgical Uveitis
- •Acute bacterial endophthalmitis
- •Chronic bacterial endophthalmitis
- •Fungal endophthalmitis
- •Endogenous endophthalmitis
- •Lens-induced uveitis
- •Toxic anterior segment syndrome (TASS)
- •Laser-induced uveitis
- •Case 18-1
- •References
- •Anterior Uveitis
- •Epidemiology
- •Clinical description
- •Idiopathic anterior uveitis
- •Diagnostic workup
- •Treatment
- •HLA-B27–associated anterior uveitis
- •Epidemiology
- •Demographics and clinical findings
- •Etiology
- •HLA-B27–associated anterior uveitis with systemic disease
- •Ankylosing spondylitis
- •Etiology
- •Treatment
- •Reactive arthritis (Reiter’s syndrome)
- •Juvenile idiopathic arthritis
- •Diagnosis
- •Pathology
- •Differential diagnosis
- •Treatment and prognosis
- •Psoriatic arthropathy
- •Inflammatory bowel disease
- •Whipple’s disease
- •Disease associations
- •Fuchs’ heterochromic iridocyclitis
- •Etiology
- •Treatment and prognosis
- •Kawasaki disease
- •Tubulointerstitial nephritis and uveitis syndrome (TINU)
- •Pathogenesis
- •Glaucomatous cyclitic crisis
- •Schwartz syndrome
- •Anterior segment ischemia
- •Lens-induced uveitis
- •Anterior uveitis associated with AIDS
- •Other disease associations
- •References
- •Scleritis
- •Episcleritis
- •Scleritis
- •Disease associations
- •Other causes of scleritis
- •Diagnostic testing
- •Pathogenesis
- •Differential diagnosis
- •Treatment
- •References
- •Intermediate Uveitis
- •Epidemiology
- •Clinical manifestations
- •Prognosis
- •Differential diagnosis
- •Multiple sclerosis
- •Etiology
- •Treatment
- •Corticosteroids
- •Immunosuppressive agents
- •Surgery
- •Case 21-1
- •Case 21-2
- •References
- •Sarcoidosis
- •Epidemiology
- •Etiology
- •Clinical manifestations
- •Anterior uveitis
- •Posterior segment findings
- •Systemic involvement
- •Pathology
- •Diagnosis
- •Treatment
- •Case 22-1
- •References
- •Sympathetic Ophthalmia
- •Clinical appearance and prevalence
- •Classic presentation
- •Sequelae
- •Tests and immunologic characteristics
- •Dalen–fuchs nodules
- •Preservation of the choriocapillaris
- •Therapy
- •Corticosteroids
- •Immunosuppressive agents
- •Case 23-1
- •Case 23-2
- •References
- •Vogt–Koyanagi–Harada Syndrome
- •Clinical aspects
- •Systemic findings
- •Ocular findings
- •Course of disease
- •Laboratory tests, etiology, and histopathology
- •Antigen-specific and immune responses
- •Vogt–Koyanagi–Harada syndrome versus sympathetic ophthalmia
- •Therapy
- •Cataract extraction
- •Case 24-1
- •Case 24-2
- •References
- •Birdshot Retinochoroidopathy
- •Clinical manifestations
- •Ocular examination and ancillary clinical tests
- •Tests, histology and etiology
- •Therapy
- •Case 25-1
- •Case 25-2
- •References
- •Behçet’s Disease
- •Clinical manifestations
- •Oral aphthous ulcers
- •Skin lesions
- •Genital ulcers
- •Ocular disease
- •Retinal disease
- •Complications
- •Minor criteria
- •Arthritis
- •Vascular alterations
- •Neurologic involvement (neuro-Behçet’s disease)
- •Immunologic and histologic considerations
- •Role of T cells (but other cells count too!)
- •HLA typing and single nucleotide polymorphisms (SNPs)
- •Therapy
- •Systemic corticosteroids
- •Cytotoxic and antimetabolic agents
- •Colchicine
- •Interferon-α
- •Ciclosporin and tacrolimus (FK506)
- •Anti-TNF therapy (infliximab)
- •Other approaches
- •Case 26-1
- •Case 26-2
- •Case 26-3
- •References
- •Retinal Vasculitis
- •Clinical characteristics
- •Ocular vasculitic disorders without systemic disease
- •Eales’ disease
- •Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN syndrome)
- •Frosted branch angiitis
- •Scleritis
- •Ocular vasculitic disorders with systemic disease
- •Systemic lupus erythematosus
- •Polyarteritis nodosa
- •Wegener’s granulomatosis
- •Whipple’s disease
- •Inflammatory bowel disease
- •Autoantibodies to Sjögren’s syndrome A antigen
- •Retinal vein occlusion
- •Relapsing polychondritis
- •Viral diseases
- •Multiple sclerosis
- •Tuberculosis
- •Rheumatoid arthritis
- •Kikuchi–Fujimoto disease
- •Susac syndrome
- •Sweet syndrome
- •References
- •Serpiginous Choroidopathy
- •Clinical features
- •Pathology
- •Etiology
- •Differential diagnosis
- •Therapy
- •Case 28-1
- •Case 28-2
- •Case 28-3
- •References
- •White-Dot Syndromes
- •Multiple evanescent white-dot syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Multifocal choroiditis and panuveitis
- •Clinical findings
- •Punctate inner choroidopathy
- •Laboratory findings
- •Therapy
- •Acute retinal pigment epitheliitis
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute posterior multifocal placoid pigment epitheliopathy
- •Clinical findings
- •Etiology
- •Therapy
- •Subretinal fibrosis and uveitis syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute zonal occult outer retinopathy (AZOOR) and the azoor complex diseases
- •Case 29-1
- •Case 29-2
- •Case 29-3
- •References
- •Masquerade Syndromes
- •Intraocular lymphoma
- •Non-Hodgkin’s lymphoma of central nervous system
- •Diagnosis
- •Treatment
- •Systemic Non-Hodgkin’s lymphoma metastatic to eye
- •Lymphoid hyperplasia of uvea
- •Other malignant processes manifesting as uveitis
- •Paraneoplastic syndromes
- •Multiple sclerosis
- •Other nonmalignant conditions
- •References
- •Introduction
- •Age-related macular degeneration
- •Animal work
- •Animal laser model
- •Ccl2 and Ccr2 knockout model
- •Ccl2 and Cx3cr1 double knockout model
- •CEP induced AMD-like disease
- •Human data
- •Autoimmunity
- •Gene associations
- •Macrophages and other cells
- •Histopathology
- •The downregulatory immune environment
- •Should we consider immunotherapy?
- •Diabetic retinopathy
- •Diabetes and the immune process
- •Animal work
- •Human observations
- •Can we begin to think about immune therapy for diabetes and diabetic retinopathy?
- •Glaucoma
- •Autoantibodies and glaucoma
- •Cellular immunity and glaucoma
- •Can immune intervention help alter the course of glaucoma?
- •References
- •Index
Part 2 • Diagnosis
Chapter 4 Development of a Differential Diagnosis
Box 4-1 Classification of uveitis
1.Is the disease acute or chronic?
2.Is the inflammation granulomatous or nongranulomatous?
3.Is the disease unilateral or bilateral?
4.Where is the inflammation located in the eye?
5.What are the demographics of the patient?
6.What associated symptoms does the patient have?
7.What associated signs are present on physical examination?
8.What is the time course of the disease and response to previous therapy?
symptoms. Other data, such as the type and anatomic location of the inflammation, are obtained from the ocular examination. Again, the need for information about systemic and neurologic signs necessitates a careful physical and neurologic examination of the patient by the ophthalmologist or by a consulting internist, internal medicine subspecialist, neurologist, or general medical practitioner.
Once the uveitis has been classified, a preliminary differential diagnosis should be generated. The answers to each of the questions in Box 4-1 will generate a list of possible diagnoses. The diagnoses that appear most frequently on these lists are then the most likely cause of the disorder. Ancillary examinations, including laboratory tests or specialized examinations such as radiography, electrophysiology, or a surgical procedure such as a diagnostic vitrectomy, can then be obtained to discern among the most likely diagnoses. In the next chapter on diagnostic testing, we show that the ‘shotgun approach’ of ordering every diagnostic test available will mislead the clinician into making the wrong diagnosis.
Classifying uveitis
1. Is the disease acute or chronic?
Acute occurrences of uveitis usually have a sudden onset and last up to 6 weeks. The most common causes are listed in Box 4-2. Most occurrences of anterior uveitis, such as HLA- B27-associated iritis and idiopathic anterior uveitis, fall into this category. Other diseases that typically cause acute uveitis include Vogt–Koyanagi–Harada syndrome, postoperative bacterial infection, toxoplasmosis, many of the ‘white-dot syndromes,’ such as acute posterior multifocal placoid pigment epitheliopathy (APMPPE) and multiple evanes cent white-dot syndrome (MEWDS), and traumatic iritis. Although many diseases can cause acute uveitis, these are the conditions to consider first in the differential diagnosis. Chronic forms of uveitis have an insidious onset and typically last longer than 6 weeks. Other groups have defined a limited duration of uveitis as lasting 3 months or less, and persistent disease as lasting longer than 3 months.3 Again, although many diseases can cause a uveitis that persists longer than 6 weeks, the uveitides that are characteristically chronic are listed in Box 4-2. Knowing whether the uveitis is acute or chronic is never sufficient to make a diagnosis, but it may aid in the diagnostic process.
Box 4-2 Causes of acute and chronic uveitis
ACUTE UVEITIS
Most cases of anterior uveitis: idiopathic, ankylosing spondylitis, Reiter’s syndrome, Fuchs’ heterochromic iridocyclitis
Vogt–Koyanagi–Harada syndrome Toxoplasmosis
White-dot syndromes: acute posterior multifocal placoid pigment epitheliopathy and multiple evanescent white-dot syndrome
Acute retinal necrosis Postsurgical bacterial infection Trauma
CHRONIC UVEITIS
Juvenile rheumatoid arthritis Birdshot choroidopathy Serpiginous choroidopathy Tuberculous uveitis
Postoperative uveitis (Propionibacterium acnes, fungal) Intraocular lymphoma
Sympathetic ophthalmia Multifocal choroiditis Sarcoidosis
Intermediate uveitis/pars planitis
2. Is the inflammation granulomatous or nongranulomatous?
The ocular examination offers a unique opportunity to determine the type of infiltrating inflammatory cells involved in the disease process without taking a biopsy sample for histologic analysis. In anterior uveitis, inflammatory cells attach to the corneal endothelium in conglomerates called keratic precipitates (KPs). The appearance of KPs has been used to classify the inflammatory process as granulomatous or nongranulomatous. The more common nongranulomatous type of KP is characterized by fine white collections of lymphocytes, plasma cells, and pigment. These precipitates can form in any disease and cause an anterior uveitis; the finding of nongranulomatous KPs does not help tremendously in the formulation of a differential diagnosis other than to alert the clinician that anterior inflammatory disease has occurred in the eye. Granulomatous KPs are large, greasy-appearing collections of lymphocytes, plasma cells, and giant cells (see Fig. 4-2). The finding of granulomatous KPs, also called ‘mutton-fat’ KPs, on slit-lamp examination can be a useful diagnostic clue. Patients with granulomatous KPs usually have a history of a chronic disease with an insidious onset, and frequently have posterior segment disease in addition to their anterior segment inflammation. Other ocular findings suggestive of granulomatous inflammation are iris nodules and choroidal granulomas. Importantly, the finding of granulomatous inflammation in the eye suggests a unique set of diagnostic possibilities that are listed in Box 4-3.
3. Is the disease unilateral or bilateral?
Although one eye may be affected first, uveitis resulting from most causes involves both eyes within the first several
52
Box 4-3 Causes of granulomatous inflammation in
the eye
Sarcoidosis
Sympathetic ophthalmia
Uveitis associated with multiple sclerosis
Lens-induced uveitis
Intraocular foreign body
Vogt–Koyanagi–Harada syndrome
Syphilis
Tuberculosis
Other infectious agents
Box 4-4 Causes of unilateral uveitis
Sarcoidosis
Postsurgical uveitis
Intraocular foreign body
Parasitic disease
Acute retinal necrosis
Behçet’s disease
months. Therefore, the history that the disease is both chronic and unilateral can help in diagnosing the condition. Diseases that frequently involve a single eye, even after months or years of the disorder, are listed in Box 4-4. Parasitic disease typically involves one eye, although some of the diseases, such as toxoplasmosis, occur bilaterally. Uveitis after ocular surgery or the presence of an intraocular foreign body is almost exclusively unilateral. The one disease that most ophthalmologists think of as a bilateral disease but which we see involving a single eye in a number of patients is sarcoidosis. Similarly, we have seen a number of patients with Behçet’s disease that involved a single eye, especially those of Asian descent.
4. Where is the inflammation located in the eye?
It is important to determine the anatomic position of the inflammation within the eye. Table 4-1 delineates three similar methods for the anatomic classification of intraocular inflammatory disease. We based our anatomic classification on the scheme proposed by the International Uveitis Study Group.4 This was modified by the SUN Working Group by dividing the anatomic nomenclature into anterior, intermediate, posterior, and panuveitis and functions to both simplify and standardize the way the disease is described.4 In addition to classifying uveitis as anterior, intermediate, or posterior uveitis or panuveitis, we note whether there is a predominant involvement of the cornea (keratouveitis), sclera (sclerouveitis), or retinal vasculature (retinal vasculitis) because these findings point to specific causes.
Anterior uveitis describes a disease limited predominantly to the anterior segment of the eye. Other terms used in the literature for anterior uveitis are iritis, iridocyclitis, and anterior cyclitis. The inflammation is characterized by conjunctival hyperemia, anterior chamber cell and flare, KPs, and
Classifying uveitis
Box 4-5 Causes of anterior uveitis
Idiopathic
Ankylosing spondylitis
Reiter’s syndrome
Inflammatory bowel disease
Psoriatic arthritis
Behçet’s disease
HLA-B27-associated disease
Juvenile rheumatoid arthritis
Fuchs’ heterochromic iridocyclitis
Sarcoidosis
Syphilis
Glaucomatocyclitic crisis
Masquerade syndromes
Table 4-1 Anatomic classification of uveitis
|
|
|
SUN Working |
IUSG* |
Tessler† |
Group3 |
|
– |
|
Sclerouveitis |
|
|
|
|
|
– |
|
Keratouveitis |
|
|
|
|
|
Anterior uveitis |
Anterior uveitis |
Anterior uveitis |
|
|
|
|
|
|
Iritis |
Iritis |
Iritis |
|
|
|
|
|
Anterior cyclitis |
Iridocyclitis |
Iridocyclitis |
|
|
|
|
Iridocyclitis |
|
Anterior cyclitis |
|
|
|
|
|
Intermediate uveitis (formerly |
Intermediate |
Intermediate uveitis |
|
known as pars planitis) |
uveitis |
|
|
|
|
|
|
|
Posterior cyclitis |
Cyclitis |
Pars planitis |
|
|
|
|
|
Hyalitis |
Vitritis |
Posterior cyclitis |
|
|
|
|
|
Basal retinochoroiditis |
Pars planitis |
Hyalitis |
|
|
|
|
Posterior uveitis |
Posterior uveitis |
Posterior uveitis |
|
|
|
|
|
Focal, multifocal, or diffuse |
Choroiditis |
Focal, multifocal or |
|
choroiditis |
|
diffuse choroiditis |
|
|
|
|
|
Chorioretinitis or |
Retinitis |
Retinitis, |
|
retinochoroiditis |
|
chorioretinitis, or |
|
|
|
|
retinochoroiditis |
|
|
|
|
Neuroretinitis |
– |
Neuroretinitis |
|
|
|
|
|
Panuveitis |
– |
Panuveitis |
|
|
|
|
|
*From Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103: 234–5.
†From Tessler HH. Classification and symptoms and signs of uveitis. In: Duane TD, Jaeger EA, eds. Clinical ophthalmology, vol 4. Philadelphia: JB Lippincott, 1987; 1–10.
iris abnormalities, including posterior synechiae and peripheral anterior synechiae. A mild cellular inflammatory response in the anterior vitreous is often seen. The common causes of anterior uveitis are listed in Box 4-5.
Intermediate uveitis is the anatomic diagnosis that causes the most confusion among ophthalmologists. However, the proper classification of a uveitis as intermediate is very important because an underlying cause for the disease can often be determined. Intermediate uveitis is characterized
53
Part 2 • Diagnosis
Chapter 4 Development of a Differential Diagnosis
Box 4-6 Causes of intermediate uveitis
Sarcoidosis
Inflammatory bowel disease
Multiple sclerosis
Lyme disease
Pars planitis*
Box 4-8 Causes of panuveitis
Syphilis Sarcoidosis
Vogt–Koyanagi–Harada syndrome Infectious endophthalmitis Behçet’s disease
*Not an etiologic diagnosis, but patients with intermediate uveitis of the par planitis subtype tend to have a worse prognosis.
Box 4-7 Causes of posterior uveitis
FOCAL RETINITIS
Toxoplasmosis
Onchocerciasis
Cysticercosis
Masquerade syndromes
MULTIFOCAL RETINITIS
Syphilis
Herpes simplex virus
Cytomegalovirus
Sarcoidosis
Masquerade syndromes
Candidiasis
Meningococcus
FOCAL CHOROIDITIS
Toxocariasis
Tuberculosis
Nocardiosis
Masquerade syndromes
MULTIFOCAL CHOROIDITIS
Histoplasmosis
Sympathetic ophthalmia
Vogt–Koyanagi–Harada syndrome
Sarcoidosis
Serpiginous choroidopathy
Birdshot choroidopathy
Masquerade syndromes (metastatic tumor)
by inflammation that primarily affects the vitreous and peripheral retina. Aggregates of inflammatory cells are frequently seen in the inferior vitreous and have been termed vitreous snowballs. Similarly, the accumulation of inflammatory cells and debris along the pars plana and ora serrata have been called snowbanks. A mild anterior uveitis often coexists, and cystoid macular edema is a frequent finding. The conditions associated with intermediate uveitis are listed in Box 4-6.
Disease limited to the posterior segment of the eye, particularly to the retina and choroid, is termed posterior uveitis. A large number of diseases cause posterior uveitis, so to further subdivide the disorders we classify posterior uveitis as predominantly a retinitis or choroiditis and as a focal or multifocal disease. The disorders that cause focal and multifocal retinitis and choroiditis are listed in Box 4-7. The term panuveitis is reserved for diseases that involve all segments of the eye, typically with a severe sight-reducing inflammatory response. The common causes of panuveitis are listed in Box 4-8.
Severe scleritis in association with uveitis is most frequently seen in patients with underlying connective tissue diseases such as rheumatoid arthritis and ankylosing spondylitis. Inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, also cause sclerouveitis. Finally, severe retinal vasculitis is associated with a subset of diseases that cause uveitis. Like scleritis, retinal vasculitis is often associated with underlying connective tissue disease. A full list of the disorders that cause retinal vasculitis can be found in Chapter 27.
5. What are the demographics of the patient?
Demographic information can lead the ophthalmologist to suspect certain types of uveitis, although there are always patients whose presentation varies from the usual age, gender, race, ethnic heritage, or social parameters characteristic of any particular disease. The age of the patient can be particularly useful in developing a differential diagnosis because certain causes of uveitis are more common among patients of specific age groups. A list of the diseases that occur more frequently in certain age groups is found in Table 4-2. One must be careful, however, not to rigidly apply these guidelines to patients. For example, although intraocular lymphoma is typically found in patients older than 65 years, we have seen patients with this disease in their 30s. Nevertheless, these guidelines are clearly useful, especially in diagnosing uveitis in children. Other demographic considerations in patients with uveitis are listed in Table 4-3.
6. What associated symptoms does the patient have?
As stated in Chapter 3, a thorough medical history is often the key to accurate diagnosis. Specific symptoms, both those relating to the eye and those suggesting systemic disease, should lead the clinician to suspect certain types of uveitis. We find that carefully defining a patient’s symptoms is the most important step in determining the correct diagnosis. Many of the symptoms that suggest specific diagnoses are listed in Table 4-4. However, the enthusiasm to classify the patient within a diagnostic category may tempt the clinician to stretch the symptoms to fit a particular disease. For example, a patient who noted mild knee pain after playing basketball for the first time in 2 years should not be classified as having a chronic arthritis consistent with rheumatoid arthritis. Similarly, ringing in the ears after a 4-hour rock concert does not qualify as tinnitus suggestive of Vogt– Koyanagi–Harada syndrome. Importantly, the clinician must be careful not to suggest symptoms to the patient. Avoid asking questions such as ‘You must have had some joint pain with this, haven’t you?’ Although it is important
54
Table 4-2 Age considerations in patients with uveitis*
Age (yr) |
Diagnostic Considerations |
<5 |
Juvenile rheumatoid arthritis |
|
Toxocariasis |
|
Postviral neuroretinitis |
|
(Retinoblastoma) |
|
(Juvenile xanthogranuloma) |
|
Leukemia |
|
|
5–15 |
Juvenile rheumatoid arthritis |
|
Pars planitis |
|
Toxocariasis |
|
Postviral neuroretinitis |
|
Sarcoidosis |
|
Leukemia |
|
|
16–25 |
Pars planitis |
|
Ankylosing spondylitis |
|
Idiopathic anterior uveitis |
|
Toxoplasmosis |
|
Sarcoidosis |
|
Acute retinal necrosis |
|
|
25–45 |
Ankylosing spondylitis |
|
Idiopathic anterior uveitis |
|
Fuchs’ heterochromic iridocyclitis |
|
Idiopathic intermediate uveitis |
|
Toxoplasmosis |
|
Behçet’s disease |
|
Idiopathic retinal vasculitis |
|
Sarcoidosis |
|
White-dot syndromes |
|
Vogt–Koyanagi–Harada syndrome |
|
AIDS, syphilis |
|
Serpiginous choroidopathy |
|
|
45–65 |
Birdshot retinochoroiditis |
|
Idiopathic anterior uveitis |
|
Idiopathic intermediate uveitis |
|
Idiopathic retinal vasculitis |
|
Behçet’s disease |
|
Serpiginous choroidopathy |
|
Acute retinal necrosis |
|
|
>65 |
Idiopathic anterior uveitis |
|
Idiopathic intermediate uveitis |
|
Idiopathic retinal vasculitis |
|
Serpiginous choroidopathy |
|
(Masquerade syndromes) |
|
|
*Parentheses indicate noninflammatory diseases.
to interview patients about their medical history, the use of a standardized questionnaire helps ensure that symptoms are not missed or inappropriately suggested.
7. What associated signs are present on physical examination?
If it is rare to find ophthalmologists taking a detailed medical history in the office, it is almost unheard of for a detailed physical examination to be performed in the office. Unless you are prepared to do a thorough physical examination, it is probably more practical to refer patients to their primary care physician for this part of the evaluation. Nevertheless, it is fruitful for the ophthalmologist to examine a few things before making the referral. We have found that examination
|
Classifying uveitis |
|
|
|
|
|
|
|
|
|
|
Table 4-3 Demographic considerations in uveitis |
|
||
Factor |
Disease Risks |
|
|
Female |
Pauciarticular juvenile rheumatoid |
|
|
|
arthritis, chronic anterior uveitis |
|
|
|
|
|
|
Male |
Ankylosing spondylitis, |
|
|
|
sympathetic ophthalmia |
|
|
|
|
|
|
American black |
Sarcoidosis |
|
|
|
|
|
|
Native American |
Vogt–Koyanagi–Harada syndrome |
|
|
|
|
|
|
Midwestern American |
Presumed ocular histoplasmosis |
|
|
|
|
|
|
Japanese* |
Vogt–Koyanagi–Harada syndrome |
|
|
|
Behçet’s syndrome |
|
|
|
|
|
|
Mediterranean ancestry |
Behçet’s syndrome |
|
|
|
|
|
|
Central American |
Cysticercosis, onchocerciasis |
|
|
|
|
|
|
South American |
Cysticercosis, toxoplasmosis |
|
|
|
|
|
|
West African |
Onchocerciasis |
|
|
|
|
|
|
Intravenous drug user |
Fungal endophthalmitis, AIDS |
|
|
|
|
|
|
Promiscuous sexual activity |
AIDS, syphilis |
|
|
|
|
|
|
Frequent hiking in wooded areas |
Lyme disease |
|
|
|
|
|
|
*Not in Americans of Japanese extraction.
of the skin can be extremely rewarding in diagnosing uveitis. We have discovered sarcoid granulomas, rashes consistent with Lyme disease and syphilis, and Kaposi’s sarcoma. A brief examination of the joints for signs of inflammation is also useful, and a screening neurologic examination is warranted, especially in patients who may have intraocular lymphoma, sarcoidosis, or Behçet’s disease. Table 4-4 lists the systemic signs associated with specific uveitic conditions.
8. What is the time course of the disease and response to previous therapy?
The time course of the disease and the response to therapy can provide useful information in determining the cause. Is the disease responsive to antiinflammatory therapy? Does it require continued corticosteroid therapy? If so, how much corticosteroid is needed? Is the disease resistant to corticosteroid therapy? These questions can help the clinician determine the correct diagnosis. In general, infectious diseases may initially improve with antiinflammatory therapy but later worsen. Postoperative endophthalmitis caused by Propionibacterium acnes typically improves temporarily with topical or systemic corticosteroid therapy but then recurs. A temporary and partial response to therapy also suggests that the ocular inflammation may be associated with a chronic systemic disease such as sarcoidosis or a malignancy-like lymphoma. A long history of intermittent response to therapy tends to be more suggestive of a chronic noninfectious and nonmalignant disease, because both infection or malignancy often become evident after several years.
The old adage, ‘When you hear hoofbeats, think of horses and not zebras,’ also applies to the evaluation of the patient with uveitis. Common diseases are frequently the cause of uveitis even in cases that are difficult to diagnose. Table 4-5 lists the most common causes of anterior and posterior uveitis from two published surveys of patients with uveitis.
55
- #28.03.202681.2 Mб0Ultrasonography of the Eye and Orbit 2nd edition_Coleman, Silverman, Lizzi_2006.pdb
- #
- #
- #
- #28.03.202621.35 Mб0Uveitis Fundamentals and Clinical Practice 4th edition_Nussenblatt, Whitcup_2010.chm
- #
- #
- #28.03.202627.87 Mб0Vaughan & Asbury's General Ophthalmology 17th edition_Riordan-Eva, Whitcher_2007.chm
- #
- #
- #
